Despite the known importance of zinc for human immunity, molecular insights into its roles have remained limited. Here we report a novel autosomal recessive disease characterized by absent B cells, agammaglobulinemia and early onset infections in five unrelated families. The immunodeficiency results from hypomorphic mutations of SLC39A7, which encodes the endoplasmic reticulum-to-cytoplasm zinc transporter ZIP7. Using CRISPR-Cas9 mutagenesis we have precisely modeled ZIP7 deficiency in mice. Homozygosity for a null allele caused embryonic death, but hypomorphic alleles reproduced the block in B cell development seen in patients. B cells from mutant mice exhibited a diminished concentration of cytoplasmic free zinc, increased phosphatase activity and decreased phosphorylation of signaling molecules downstream of the pre-B cell and B cell receptors. Our findings highlight a specific role for cytosolic Zn 2+ in modulating B cell receptor signal strength and positive selection.
T he molecular dissection of primary immunodeficiencies is a powerful means of elucidating genes and pathways critical for immune function. In the case of B cell development, linkage analysis and subtractive hybridization in boys with X-linked agammaglobulinemia (XLA) led to the discovery of the first B cell immunodeficiency disease gene, Bruton's tyrosine kinase (BTK) 1, 2 . This kinase is now the target of drugs effective in treating numerous B cell malignancies 3 . Although its expression is not confined to the B cell lineage, it is in B cells that BTK performs its major non-redundant function as a signaling molecule downstream of the nascent pre-B and B cell receptors (BCR).
B cells must rearrange first heavy and then light chain immunoglobulin (Ig) genes as they proceed through an orderly program of development, and pass corresponding quality control checkpoints that signal the expression of first the pre-BCR and then the BCR, respectively. Confirming the importance for developing human B cells of survival signals emanating from the pre-BCR/BCR, autosomal recessive causes of B cell deficiency have been identified in An essential role for the Zn 2+ transporter ZIP7 in B cell development Articles NaTURe ImmUNOlOgy the antigen receptor itself (IGHM, IGLL1), its signaling adaptors (CD79A, CD79B) and other downstream signal transducers (BLNK, PIK3R1) . Together with BTK, these defects of pre-BCR and BCR signaling account for the vast majority of early onset agammaglobulinemias, and few patients remain without a molecular diagnosis in the USA and Europe [4] [5] [6] . The divalent cations, Ca 2+ and Mg 2+ , are well established as mediators of lymphocyte cell signaling and inherited deficiency in their transmembrane transporters (ORAI1 (ref. 7 ) and MAGT1 (ref. 8 )) causes a combined B and T cell immunodeficiency and a T and NK cell immunodeficiency, respectively. A third divalent cation, Zn 2+ , contributes to the structural and functional integrity of over 3,000 proteins and is tightly regulated by buffering, and by 14 SLC39A (ZIP) and 10 SLC30A (ZnT) Zn 2+ transporters, which control the movement of Zn 2+ between the cytosol and the extracellular space or cytoplasmic organelles 9 . Dietary zinc deficiency causes lymphopenia 10 and loss of ZIP10 has also been associated with B cell immunodeficiency in mice 11 ; however, the mechanism(s) by which Zn 2+ might regulate lymphocyte development in humans are not established. The MHC region of human chromosome 6, which is highly enriched for immunologically relevant genes, includes a single Zn 2+ transporter, originally termed 'Really Interesting New Gene 5' or HKE4 but now known as SLC39A7. No immunological function has previously been ascribed to this gene. Here we report a novel human immunodeficiency syndrome caused by multiple loss of function alleles in SLC39A7 (ZIP7), which lead to reduced B cell signaling at the positive selection checkpoints.
Results
A novel human immunodeficiency syndrome. We used whole exome sequencing to investigate patients with early onset agammaglobulinemia and absent B cells of unknown cause, and sought candidate autosomal recessive disease genes bearing rare biallelic variants. Six individuals from five kindreds of white European, South Asian or Hispanic ancestry, were found to harbor compound heterozygous (four families) or homozygous (one family) rare variants in SLC39A7 (Fig. 1a) . This gene, not previously linked to the immune system other than by its location in the MHC complex on chromosome 6, encodes ZIP7, a ubiquitously expressed channel protein that regulates Zn 2+ egress from the endoplasmic reticulum into the cytoplasm 12 . Consistent with a causal link to a rare autosomal recessive disease, population data 13 revealed that none of the patients' variants of SLC39A7, nor any predicted null (nonsense/ frameshift/essential splice-site) alleles, occurs with a frequency of greater than 1:1,000 (Supplementary Fig. 1 ) and none has previously been found in a homozygous state. In general, patients' ethnicity matched that of the population in which the corresponding SLC39A7 variant(s) had been reported; two missense alleles each occurred in two independent kindreds of European ancestry. The five missense and two nonsense variants were all predicted to be deleterious (Combined Annotation Dependent Depletion score ≥ 25) 14 ( Supplementary Fig. 1 ). Affected individuals presented with early onset infections, agammaglobulinemia and absence of circulating B cells but normal T cell numbers and proliferative responses (Table 1 and Supplementary  Table 1 ). Naïve T cells were abundant, in keeping with age, while effector and memory subsets were correspondingly reduced but not absent. The two most severely affected children (P1 and P2, family 1) additionally showed severe blistering dermatosis (Fig. 1b) , failure to thrive and thrombocytopenia, prompting hematopoietic stem cell transplantation; this resulted in cure of immunologic abnormalities and amelioration of skin disease. Other patients have generally responded well to Ig replacement therapy alone, although P4 has suboptimal growth, enteropathy and liver dysfunction while P5 has seborrheic dermatitis. Family members who were heterozygous for a WT and a mutant allele demonstrated normal immune function.
Bone marrow examination in P1 and P2 showed a progressive failure of B cell development with an excess of pro-B cells relative to pre-B cells, and an even lower proportion of immature B cells relative to pre-B cells, similar to that seen in XLA caused by mutations in BTK (Fig. 1c) 
.
To explore the impact of disease-associated mutations, we first examined ZIP7 protein expression by immunoblotting and immunofluorescence microscopy in primary patient fibroblasts (Fig. 2a and Supplementary Fig. 2a ), and transfected cell lines . Similar to endogenous WT ZIP7 (Fig. 2c) , each variant was expressed and predominantly localized to the endoplasmic reticulum of transfected cells (Fig. 2d,e) , although the protein products of nonsense variants were truncated when visualized on SDS-PAGE (Fig. 2b) . The detrimental effects of missense amino acid substitutions were illuminated by modeling into the predicted multi-pass membrane channel structure of human ZIP7, on the basis of alignment with a recently solved bacterial ZIP (BpZIP; 26% sequence identity) (Fig. 2f,g and Supplementary Fig. 1c ) 15 . In most cases, the amino acid change (P190A, L217P, G458A) involves either a glycine or proline, residues that are often conserved and known to be critical for membrane protein structure. In the case of P190A and L217P, the removal and introduction of a proline, respectively, is likely to affect the conformation and/or dynamics of their respective helices, and perhaps that of the intervening, histidine-rich cytoplasmic loop. The G458A change will disrupt packing interactions of helices H8 and H2 in the protein interior, which, with H2 lining the active site, is likely to disrupt function. Of the remaining two mutations, T395I is at first sight enigmatic, because it corresponds to a semi-conservative change of a lipid-exposed residue. However, this most probably reflects an alignment gap; once both H6 helices are aligned, the Thr395 corresponds to Glu240 in BpZIP (or an adjacent residue), one of the active site residues coordinating Zn 2+ in the channel. The effect of the final E363K mutation is very clear, as this will place a positively charged side chain in or near this active site (Fig. 2f,g ).
These analyses strongly suggested that disease alleles were either null or hypomorphic with respect to Zn 2+ transport function. To test this hypothesis, we compared the function of P190A and E363K missense mutants, which were co-expressed in the most severely affected family 1, with WT ZIP7, by injecting messenger RNA transcripts into Xenopus oocytes and visualizing Zn 2+ ingress by means of a Zn 2+ -sensitive dye ( Fig. 2h and Supplementary Fig.  2b ,c). In keeping with hypomorphic behavior, the Zn 2+ signal generated by either mutant ZIP7 was significantly reduced compared with WT (Fig. 2h) , despite similar amounts of protein expression ( Supplementary Fig. 2c ). Similar data were obtained in mammalian cells transfected with a eCALWY-4 fluorescence energy transfer (FRET) probe for cytoplasmic Zn 2+ alongside WT or mutant ZIP7 ( Supplementary Fig. 2d ,e) 16 . Taken together, these studies suggest residual ZIP7 protein expression but reduced function in patients bearing pathogenic mutations. Mouse ZIP7 hypomorphs model human disease. To model the human disease, we used CRISPR-Cas9 genome editing 17 to generate C56BL/6J (B6) mice carrying a ZIP7 P198A mutation, orthologous to the most N-terminal human P190A mutation found in two independent kindreds. We chose a knock-in rather than a knockout approach because we suspected complete loss of function would be embryonic lethal. The error-prone non-homologous end-joining repair pathway nonetheless generated a series of different ZIP7 alleles in mouse zygotes, which allowed us to investigate a range of phenotypes. These variants included null alleles due to frameshift mutations, the P198A mutation itself and an insertional mutant H199QV, which was also expressed at the protein level (Fig. 3a) .
Mice with homozygous (ZIP7 P198A/P198A or ZIP7 H199QV/H199QV ) or compound heterozygous (ZIP7 P198A/H199QV ) hypomorphic mutations Articles NaTURe ImmUNOlOgy demonstrated profound B cell immunodeficiency (Fig. 3b) , whereas heterozygous mice with WT alleles had normal B cell numbers.
Other effects of the ZIP7 mutations on growth and skin varied by allele, with severity ranging from WT < H199QV < P198A < null. Homozygous ZIP7 H199QV/H199QV and compound heterozygous ZIP7 P198A/H199QV mice showed mild weight restriction compared with WT, whereas ZIP7 P198A/P198A mice were growth retarded with mottled gray fur, and few of these animals survived beyond 6 weeks (Fig. 3c,d ). ZIP7
−/P198A and ZIP7 −/H199QV mice carrying the null allele could not be obtained. These findings are consistent with an absolute requirement for some residual ZIP7 function during embryonic development, albeit less than that required for developing B cells. The murine ZIP7 mutations therefore lead to quantitative traits affecting the skin and growth, and a qualitative trait affecting B cell development (Fig. 3e) .
To investigate the role of ZIP7 in B cell development, we focused on mice homozygous for the hypomorphic P198A allele, mimicking one of the human disease variants. (Fig. 4a,b) 
18
. Peripheral B cell numbers were further reduced in the spleen with progressive loss from , n = 5), respectively, in WT mice. B cells constituted only 0.76% (0.76-0.77%, 95% CI) of total blood lymphocytes in 4-week-old ZIP7 P198A/P198A mice, compared to 27.96% (27.71-28 .21%, 95% CI) in age-matched WT controls; and serum IgM antibody concentrations in 4-6 week ZIP7 P198A/P198A and WT mice were 104 μ g ml −1 (103-106 μ g ml
, 95% CI) and 383 μ g ml −1 (378-388 μ g ml
, 95% CI), respectively. Because ZIP7 P198A/ P198A mice rarely survived long after weaning, endogenous IgG production could not be assessed. However, mice of the milder hypomorphic genotype ZIP7 P198A/H199QV showed a dramatic decline in IgG concentrations beyond this age (146-150 μ g ml −1 , 95% CI, compared , endoplasmic reticulum marker calnexin (middle, red) and both ZIP7 and calnexin together (right, colocalization shows as orange signal). d, The distribution of recombinant FLAG-tagged WT or indicated missense ZIP7 proteins in HEK293T cells, transfected individually and probed with primary antibodies against FLAG (green) and calnexin (red; orange signal thus indicates colocalization in the endoplasmic reticulum). Scale bar, 10 µ m. e, As in d, but recombinant truncation mutants were not FLAG-tagged so were probed with primary anti-ZIP7 antibody. Images c-e are representative of three independent experiments and Pearson coefficients were uniformly > 0.6. f,g, The location of missense mutations in the predicted protein structure of ZIP7, modeled on the structure of Bordetella pertussis ZIP using PyMOL; f, face-on view and g, side view of ZIP7. M1 and M2 represent Zn 2+ ions bound in the channel, TM indicates the transmembrane region, ER the endoplasmic reticulum. h, Hypomorphic human SLC39A7 alleles were expressed in Xenopus oocytes and ZIP7-mediated Zn 2+ flux revealed following exposure of Zinquin-loaded oocytes to extracellular zinc (see Methods). Normalized mean fluorescence signal intensity (in arbitrary units, A.U.) is shown with standard deviation (s.d.) for one experiment (WT, n = 3 oocytes; P190A, n = 4; E363K, n = 3, uninjected, n = 2), representative of four independent experiments. Statistical comparison was by one-way analysis of variance (ANOVA) with Tukey's post-hoc test (d.f. = 8); *P = 0.0309; **P = 0.0120; ***P = 0.0066; NS, non-significant.
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NaTURe ImmUNOlOgy to 1,830-1,870 μ g ml −1 , 95% CI, in WT mice, aged 7-13 weeks). T cell development and peripheral T cell numbers were normal, as were other leukocyte populations ( Supplementary Fig. 3 ). These data thus confirmed a selective and profound failure of B cell development in ZIP7-mutated mice.
Developmental arrest in ZIP7-deficient B cells. To distinguish between cell-intrinsic and -extrinsic effects on B cell development, we next generated mixed bone marrow chimeras. 30:70 mixes of CD45.1 + WT and CD45.2 + ZIP7 P198A/P198A or CD45.2 + WT whole bone marrow cells were injected intravenously into lethally irradiated CD45.1 + WT recipient mice. Eight weeks after bone marrow transfer, our analysis confirmed a B cell-intrinsic block in development, most evident in a failure to progress from the late pre-B (FrD) to immature B (FrE) cell stage, with no residual mutant cells in the recirculating FrF population (Fig. 4d ). This developmental block was mirrored in the spleen with progressive loss of transitional B cells from T1 to T3 (Fig. 4d) ; whereas ZIP7-mutated CD4 + and CD8 + T cells in thymus and spleen were not disadvantaged relative to WT cells ( Supplementary Fig. 3 ). We cannot exclude a cellintrinsic effect during the early pre-B cell stage (FrC), which might have been masked due to the small numbers of cells and difficulty of gating on CD45 allotypes at this stage. Mutant and WT immature B cells expressed kappa and lambda chains in similar ratios (87. .11% kappa and 1.11-8.93% lambda in mutant compared to 89. 40-95.64% and 1.77-7.86% in WT FrE (95% CI)), excluding a defect in the light chain rearrangement machinery.
To gain a better understanding of the impact of ZIP7 hypofunction on B cell development, we flow-sorted 100-cell aliquots of each of the Hardy fractions from ZIP7
P198A/P198A and WT mice for RNA-seq, and were able to obtain good quality RNA from
, late pre-B (FrD) and immature B cells (FrE) (Fig. 5a and Supplementary Figs. 4 and 5) . Focusing on transcripts that are modulated during mouse B cell development in ImmGen (www.immGen.org), we observed a systematically altered pattern of gene transcription consistent with developmental delay in ZIP7-deficient pre-B and immature B cells, but not at the earlier pro-B stage. Thus, the few ZIP7-deficient cells bearing the surface markers of FrE had in fact failed to exit fully from the transcriptional profile of FrD and, likewise, ZIP7-deficient cells in FrD abundantly expressed transcripts normally associated with FrC ( Fig. 5a and Supplementary Fig. 5 ). In contrast, few transcripts were differentially expressed between WT and ZIP7-deficient FrB and these did not follow a pattern of developmentally coordinated gene expression ( Supplementary Fig. 4 ). The analysis showed no statistically significant difference in expression of other ZIP and ZnT transporters in Fr D and E (see Materials and Methods).
ZIP7-deficient immature B cells continued to express Rag and Il7r genes, and failed to upregulate characteristic FrE transcripts such as Tnfrsf13c (BAFFR) and Ms4a1 (CD20) (Fig. 5a ). This indicates a failure of the normal transition from late pre-B to immature B cells, at which stage constitutive BCR signaling would normally repress FOXO1-dependent genes involved in light chain gene rearrangement (Rag1/2 and Irf4) and cell proliferation (Il7r), followed by upregulation of proteins including BAFFR that mediate peripheral survival signals 19, 20 . These key findings were confirmed at the protein level by flow cytometry, including the failure to downregulate IL7Rα (CD127; Fig. 5b ) and upregulate BAFFR and CD20 (Fig.  5c ). The same developmental blockade was observed in bone marrow samples from both patients that were compound heterozygous 
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for the P190A and E363K variants (Fig. 5d) . Thus, in contrast to BTK deficiency, ZIP7 mutation subverts both mouse and human B cell development in a profound and conserved manner.
Reduced cytoplasmic Zn
2+ . Given that ZIP7 allows the cytoplasmic ingress of Zn 2+ from the ER, we reasoned that its impaired function would alter Zn 2+ distribution in developing B cells, reducing Articles NaTURe ImmUNOlOgy its availability in the cytoplasm. To provide sufficient material to investigate this hypothesis, we generated B cell lines from WT and ZIP7 P198A/P198A mouse bone marrow maintained in IL-7-enriched media. WT and mutant cells cultured in these conditions showed comparable proliferation and differentiation to a predominantly CD43 +
CD24
+ BP-1 ± phenotype, which is considered equivalent to Fractions B-C-C' in B cell development 21, 22 . The withdrawal of IL-7 and addition of BAFF to these cultures increased the survival of IgM + IgD − immature and IgM + IgD + mature B cells from WT but not from mutant cells (Fig. 6a) . In this way, the model system recapitulated the developmental block seen in vivo.
To measure the cytoplasmic and endoplasmic reticulum concentrations of Zn 2+ at the point of blockade, we transduced aliquots of IL-7-cultured cells with either the cytoplasmic-or the endoplasmic reticulum-targeted versions of Zn 2+ FRET reporters, eCALWY-4 (dissociation constant, K d = 630 pM) or eCALWY-6 (K d = 2.9 nM) 16, 23 . We then measured the relative cytoplasmic and endoplasmic reticulum concentrations of Zn 2+ in propidium iodidenegative WT and mutant cells (> 95%) using FRET-fluorescence lifetime imaging microscopy (FRET-FLIM) 24 . An advantage of this approach is that lifetime imaging is independent of the concentration of measured fluorophore, and hence free Zn 2+ concentrations can be compared independently of reporter expression 24 . Cytoplasmic Zn 2+ concentrations were indeed lower in mutant compared to WT cells, whereas concentrations of endoplasmic reticulum Zn 2+ were equivalent (Fig. 6b,c) . In this system, the spatial distribution of cytoplasmic Zn 2+ seemed uniform in the steady state in both WT and mutant B cells (Fig. 6b) . However, local variations in Zn 2+ concentration would most probably be beyond the temporal and spatial resolutions of the current FRET-FLIM approach. It was therefore of interest to investigate the spatial distribution of endogenous ZIP7 in the relevant cell type, taking advantage of a sensitive and specific anti-human-ZIP7 antibody. Using stimulated emission depletion (STED) microscopy, we observed that > 50% ZIP7-containing structures lay within 1 µ m (and 25% within 250 nm) of the plasma membrane of activated human primary B cells, in contrast to the wider distribution seen in the cytoplasm of the much larger HEK293T cells (Fig. 6d-f) . Thus local and/or dynamic changes in Zn 2+ distribution related to ZIP7 might differ between cell types.
Developmental arrest is linked to a survival defect. In principle, the failure of ZIP-mutated B cells to complete their development could reflect a lack of requisite survival signals via the (pre-)BCR and/or accessory pathways, or excessive toxicity. Although we had failed to observe an excess of free Zn 2+ in the endoplasmic reticulum of B cells from the ZIP7 P198A/P198A mice, we considered the possibility that zinc loading of the endoplasmic reticulum could nonetheless drive an unfolded protein response (UPR), as recently described in the gut and skin of gene-targeted mice with tissuespecific ZIP7 knockout 25, 26 . However, our RNA-seq data revealed no evidence of an UPR transcriptional signature in the mutant pre-B or immature B cells, nor was Xbp1 splicing altered ( Supplementary  Fig. 6a ). Therefore, while the UPR may underlie some of the extrahematopoietic effects of ZIP7 deficiency, it is not limiting in B cells.
We next asked whether expression of the anti-apoptotic survival factor B cell lymphoma 2 (BCL2) could rescue B cell development at the pre-B to immature stage in ZIP7 P198A/P198A mice. Introduction of a B cell-specific Bcl2 transgene (from C57BL/6-Tg(BCL2)22Wehi/J) 27 increased peripheral B cell numbers in both WT and ZIP7
P198A/P198A 
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NaTURe ImmUNOlOgy mice but did not relieve the developmental block ( Supplementary  Fig. 6b-e) . This suggested that ZIP7 deficiency was not simply accelerating the death of otherwise normally developing B cells, but was fundamentally impairing the process of B cell differentiation, in keeping with the systematically altered program of gene expression detected by RNAseq.
Intact ZIP7 is required for BCR signaling. Given that Ig heavy chain expression is required for the transition from pro-B to pre-B 28 and Ig light chain expression for the pre-B to immature B cell transition 29 , we considered the possibility that ZIP7 deficiency impaired (pre-)BCR expression or signaling. To bypass the need for DNA recombination by RAG1/2 at both pro-B and pre-B cell stages, we crossed ZIP7
P198A/P198A mice with animals expressing a transgenic anti-hen egg lysozyme-(anti-HEL)-specific BCR (SW HEL mice) 30 . This generated WT and ZIP7 P198A/P198A immature SW HEL B cells expressing equivalent levels of surface BCR (Fig. 7a-c) , enabling us to interrogate the integrity of the downstream signaling pathway. Despite normal BCR expression (Fig. 7c) , ZIP7 P198A/P198A B cells still failed to mature normally, as indicated by lower cell numbers in the spleen (Fig. 7b) and an inability to upregulate CD20 and BAFFR (Fig. 7c) . Moreover, when exposed to soluble HEL (sHEL) antigen or to anti-IgM, immature ZIP7 P198A/P198A SW HEL B cells showed impaired antigen-induced signaling as judged by reduced amounts of multiple phosphorylated intermediates, including SYK, PLCγ 2 and ERK (Fig. 7d,e) . This effect was specific to B cells because signaling was unaffected in developing T cells (Supplementary Fig. 7) .
A priori, these complex effects on pathways downstream of the BCR could be mediated by variation in kinase or phosphatase activity. Since Zn 2+ is widely reported to be a negative regulator of phosphatases 31, 32 , the diminished cytoplasmic Zn 2+ associated with ZIP7 deficiency could be expected to cause pathologically elevated phosphatase activity, and thus contribute to impaired pre-BCR-and BCR-dependent signaling at the positive selection checkpoints. Constitutive phosphatase activity was indeed higher in ZIP7 P198A/P198A compared to WT pre-B and immature B cells, as measured by flow cytometry using a cell-permeable alkaline phosphatase substrate (Fig. 8a,b) . The phosphatase and tensin homolog (PTEN) is among the phosphatases previously described as being inhibited by Zn 2+ , lies upstream of FOXO1-dependent signaling 33 , and contributes to the basal phosphatase activity measured in developing B cells (Supplementary Fig. 8a ). Progressive inhibition of PTEN with its specific inhibitor BpV(phen) also revealed lower amounts of constitutive signaling to SYK, PLCγ 2 and ERK in immature ZIP7 P198A/P198A SW HEL B cells compared to WT SW HEL B cells (Fig. 8c) , but not in developing T cells ( Supplementary Fig. 7d-f ), in keeping with constitutively increased phosphatase and/or lower basal kinase activity during the stage of B cell positive selection. We could detect no variation in kinase gene expression (equivalent transcription of Syk, Blnk, Plcg2 and Mapk3 in FrE by RNA-seq); and no difference in protein expression of PLCγ 2, which we were able to detect reliably by flow cytometry (Supplementary Fig. 8b ). However, crossing ZIP7 P198A/P198A mice to mice with B cell-specific haploinsufficiency of PTEN could not reverse the block in B cell development ( Supplementary Fig. 8c,d ). These data indicate that the regulation of positive selection by ZIP7 is due to effects on multiple pathways. 
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Discussion
Our studies identify a novel form of autosomal recessive agammaglobulinemia caused by hypomorphic mutations in the endoplasmic reticulum-to-cytoplasmic zinc transporter ZIP7. This discovery implicates Zn 2+ as the third divalent cation associated with a human immunodeficiency. Despite zinc's status as a key player in protein structure and function, we are at an early stage in understanding its broader roles in homeostasis and human disease. Its tight control by buffering, and the diversity of Zn 2+ transporters, indicate that dynamic regulation of Zn 2+ distribution is critical. This conclusion is supported by knowledge that mutations in the human plasma membrane Zn 2+ transporter, SLC39A4 (ZIP4), cause total body zinc deficiency and a separate but related disease, acrodermatitis enteropathica 34 . As well as a pathognomonic dermatitis and a variable enteropathy, it is noteworthy that Zn deficiency causes lymphopenia, with accelerated apoptosis of developing B cells 35 . Importantly, the SLC39A7 (ZIP7) disease alleles are hypomorphic and exhibit partial loss of ZIP7 function. It was recently reported that complete loss of ZIP7 in cell lines causes a reduction in cytoplasmic Zn 2+ and an increase in endoplasmic reticulum Zn ; and our findings show that germline null mutations are embryonic lethal in the mouse. Tissue-specific ZIP7 knockout in the gut of mice by cremediated gene deletion reduces intestinal epithelial cell self-renewal and is associated with an endoplasmic reticulum-stress phenotype 25 . Endoplasmic reticulum stress is also caused by null mutations of catsup, encoding the Drosophila ZIP7 homolog; 37 and loss of Ke4, which encodes the ZIP7 homolog in zebrafish, results in eye, brain and skeletal malformations 38 . We postulate that residual ZIP7 function in patients protects these tissues from the effects of extreme Zn 2+ redistribution including endoplasmic reticulum stress. Our findings emphasize the specific sensitivity of mammalian B cell development to perturbations of Zn 2+ homeostasis. Whereas most tissues tolerate partial ZIP7 deficiency, developing B cells are profoundly affected and fail to progress beyond the pre-B cell stage. Such developmental blockade is characteristic of over 90% of primary agammaglobulinemias, which are typically associated with specific impairment of pre-BCR and/or BCR signaling 4 . Our data suggest that ZIP7 hypofunction likewise impedes signaling by the nascent BCR during positive selection, and that this may be in part due to defective Zn 2+ -dependent inhibition of phosphatase activity. In the chicken B cell line DT40, which does not possess a homolog of ZIP7, ZIP9-dependent Zn 2+ transport was similarly reported to enhance BCR signaling by negatively regulating phosphatase activity 39 . CD74-cre-mediated deletion of ZIP10, which transports Zn 2+ across the plasma membrane, also reduced mature B cell numbers and BCR-induced B cell proliferation in mice; yet, paradoxically, this was reportedly associated with increased BCR signaling and reduced CD45 activity 11 . Unraveling these complex effects of individual transporters will require the development of improved reporters to resolve changes in Zn 2+ levels dynamically and at higher spatial resolution.
The selective sensitivity of developing B cells to deficiency of one among several ubiquitously expressed Zn 2+ transporters might be Articles NaTURe ImmUNOlOgy considered surprising, particularly given the substantial overlap of antigen receptor signaling pathways with T cells. Non-redundant features that distinguish BCR from TCR signaling might also sensitize developing B cells to altered Zn 2+ distribution. One such distinction is the B cell-specific requirement for FOXO1 degradation to suppress RAG expression at each positive selection checkpoint 19, 40, 41 . Progression through these developmental stages requires the sequential integration of multiple signals, determined by the activity of kinases and phosphatases. Our data show how these effects are influenced by the intracellular transport of Zn 2+ and how, in principle, Zn 2+ may modulate other outcomes in a variety of signaling contexts.
Online content
Any methods, additional references, Nature Research reporting summaries, source data, statements of data availability and associated accession codes are available at https://doi.org/10.1038/ s41590-018-0295-8. Animal experiments. The generation and phenotyping of the ZIP7 mutant mice models was carried out in accordance with Animal (Scientific Procedures) Act 1986, with procedures reviewed by the clinical medicine animal care and ethical review body (AWERB), and conducted under project licenses PPL30/2966 and PPL P79A4C5BA. Animals were housed in specific pathogen free conditions, with the only reported positives on health screening over the entire time course of these studies being for Helicobacter hepaticus and Entamoeba spp. All animals were housed in social groups, provided with food and water ad-libitum and maintained on a 12 h light/12 h dark cycle (150-200 lux cool white LED light, measured at the cage floor). Phenotyping experiments were not blinded or randomized and no animals were excluded from the study.
Mice.
A CRISPR/Cas9 nuclease was designed against exon 2 of Slc39a7 (5′ -GTTACTTACCCAAGGCATGC-3′ ) using the MIT CRISPR design tool (crispr.mit.edu), which encompassed the murine equivalent (Proline-198) of the human Proline-190 residue. The target site protospacer was cloned as a linker, which was formed by annealing two oligonucleotides (5′ -CACCGTTACTTACCCAAGGCATGC-3′ , 5′ -AAACGCATGCCTTGGGTAAGTAAC-3′ ) into a short-guide RNA (sgRNA) scaffold in the pX330-U6-Chimeric_BB-CBh-hSpCas9 plasmid (Addgene no. 42230) via the BbsI restriction site, generating plasmid pX330-ZIP7. A single stranded oligonucleotide (ssODN) ( 5′ -CACCGCTCTCTGCTCCAGATCCTG CTCAGTTTTGCTTCCGGGGGGCTCCTGGGTGATGCGTTCCTCCACCT CATCGCGCATGCATTGGGTAAGTAACTTGTGGGCTCCGCCTCAAAGG CTTAAGCGGTTTTGTTC-3′ ) harboring the murine equivalent of the desired P190A (chr6_33169678_C_G) point mutation, together with a silent mutation used to mark the mutated allele with an NsiI restriction site, was used as a template for homology-directed repair. The activity of the CRISPR/Cas9 nuclease and the fidelity of the homology-directed repair were verified in mouse embryonic stem cells (JM8F6) electroporated with pX330-ZIP7 and ssODN.
For the generation of the P198A knock-in mouse model, C57BL/6J (B6) zygotes were microinjected with 20 ng μ l −1 of sgRNA, 10 ng μ l −1
NLS-Cas9 mRNA and 20 ng of ssODN. sgRNA was synthesized by in vitro transcription using the MEGAshortscript T7 Transcription Kit (ThermoFisher Scientific) from a DNA template to add a 5′ T7 polymerase binding site, prepared by polymerase chain reaction (PCR) amplification of the pX330-ZIP7 plasmid. Capped mRNA for NLS-Cas9 was generated by cloning the NLS-Cas9 complementary DNA (cDNA) from pX330-ZIP7 into pcDNA3.1, linearizing the plasmid with XhoI and using this as a template for in vitro transcription using the mMESSAGE mMACHINE T7 Ultra Kit (ThermoFisher Scientific). In vitro transcribed RNAs were purified using the MEGAclear Kit (ThermoFisher Scientific) and diluted before microinjection in 10 mM Tris.HCl pH 7.5, 0.1 mM EDTA pH 8.0. Microinjected zygotes were cultured overnight to the two-cell stage and surgically implanted into pseudopregnant CD1 females. Founder mice harboring the P198A allele in combination with putative loss-of-function alleles, were identified by genotyping using a PCR (5′ -GTTCTTAATCGGTGGGAAGCTCC-3′ and 5′ -CAGCACACCAGTCCCTGGTTTT-3′ ) amplifying a region of Slc39a7 exon 2, followed by NsiI digestion to detect the incorporation of the template sequence. All founder mice were bred with WT C57BL6/J mice and the correct P198A allele, along with several putative loss-of-function indel alleles, were segregated in the resulting F1 offspring. Mice carrying the P198A, H199QV and null alleles were crossed to pure B6 for at least six generations (to minimize the risk of co-segregating mutations caused by off target mutagenesis) and intercrossed to generate homozygotes and compound heterozygotes of the viable alleles. BCL2 (C57BL/6-Tg(BCL2)22Wehi/J), SW HEL (C57BL/6-Igh Vh10-Brink /J), Mb1Cre (Cd79b < tm1(cre)Reth), mice were maintained on the B6 background, PTEN floxed (PTEN f ) originated from the 129S1/SVimJ strain, were backcrossed to B6 for at least three generations. For bone marrow chimeras, CD45.1 + B6 mice were irradiated with two doses of 4.5 Gy spaced by 3 h and injected with at least 5 × 10 6 bone marrow cells of the indicated genotype (single samples or 30:70 mixture of WT B6.SJL CD45.1 + bone marrow and either ZIP7 P198A/P198A or WT B6 (CD45.2 + ) bone marrow). Mice were reconstituted for 8-10 weeks before immunization or analysis. All experiments included age and sex-matched littermate control animals. All experiments were approved by the NIHR or the Oxford University Ethical Review Committee and performed under UK Home Office Licence.
Zinc supplementation. ZIP7 WT and P198A-Hom bone marrow chimeras were given water with or without 0.5 mM ZnSO 4 ·7H 2 O in drinking water for the full period of reconstitution of 8 weeks 42 .
In vitro IgM stimulation. Cell suspensions from mouse bone marrow were washed and suspended in 2% FCS RPMI. Cells were warmed at 37 °C for 5 min and incubated at 37 °C (10 6 cells per well in 96-well U-bottom plates) with the indicated doses of anti-IgM F(ab) 2 (Jackson ImmunoResearch), sHEL (Sigma) for 5 min, BpV(phen) (Sigma) for 30 min. Subsequent surface and intracellular staining were performed using the BD Cytofix/Cytoperm protocol.
Flow cytometry. Cell suspensions from mouse bone marrow (two femurs and two tibias), spleen, thymus, and mesenteric lymph nodes were counted on a hemocytometer and stained in FACS buffer (DPBS supplemented with 2%FCS, 0.05% Na Azide, HEPES 10 mM) for 30 min on ice.
HEL-binding cells were detected by incubating cells with 200 ng ml −1 of unlabeled sHEL for 15 min on ice and counterstaining with HyHEL9 (a gift from Jason Cyster) conjugated to Pacific Blue. Intracellular staining was performed using the Cytofix/Cytoperm buffer (BD Bioscience) and the antibodies against phosphorylated epitopes. Data were acquired on a FACSCanto10c (BD) and analyzed with FlowJo Software (Tree Star).
mAbs against the following mouse antigens (clone) were purchased from Biolegend unless otherwise specified: B220 (RA3-6B2) AlexaFluor700, BV605, PE-Cy7, PerCP-Cy5.5; mouse BAFFR (7H22-E16) PE from BD; BP-1 PE from BD; CD3 (17-A2) BV421; CD4 (GK1.5) AlexaFluor700; CD8 (53-6.7) Per-CP-Cy5.5; CD8 (53-6.7) PerCP-Cy5.5 and PE; CD11b (M1/70) APC; CD11c (N418) FITC; CD19 (6D5) AlexaFluor700; CD20 ( mAbs against the following human antigens (clone) were purchased from BD Bioscience unless otherwise specified: CD10 (J5) FITC from Beckman Coulter; CD34 (8G12) FITC; sIgD (polyclonal) FITC from SBA; CD36 (CLB-IVC7) FITC from Sanquin; CD3 (SK7) FITC and PERCP-Cy5.5; CD19 (HIB19) FITC; CD19 (4G7) PE; cyIgM (polyclonal) SBA/Agilent technologies; TdT (HT6) FITC from Agilent; CD20 (L27) PE; sIgM (polyclonal) PE from ITK/SBA; CD16 (B73.1) PE; CD56 (C5.9) PE from Zebra/Dako; CD13 (My7) PE from Beckman Coulter; CD33 (P67.6) PE; CD138 (B-A38) PE from Diaclone); cyCD79a (HM47) PE from Beckman Coulter; CyCD179a (VpreB) (4G7) PE from Beckman Coulter; CD33 (P67.6) PerCP-Cy5.5; CD16 3G8) PerCP-Cy5.5; CD19 (SJ5C1) PerCP-Cy5.5 and APC; CD22 (S-HCL-1) APC; CD71 (LO1.1) APC; CD38 (HB7) APC and BAFFR (11C1) APC-Cy7 from Biolegend.
Alkaline phosphatase activity was measured using the cell permeant Alkaline Phosphatase Live Stain (ThermoFisher): briefly cells were washed twice in serum free DMEM with MEM Vitamins (Gibco) and Na pyruvate (Sigma), incubated at 37 °C for 30 min with the live stain diluted 1:500 in the same media; after two washes, cells were stained on ice for 15 min in FACS buffer and samples were immediately analyzed by flow cytometry.
Serum immunoglobulin levels.
Total murine serum IgG, IgM, IgA were measured using an ELISA quantitation kit from Bethyl Laboratories and following manufacturer instructions.
Whole exome sequencing. Genomic DNA from P1, P3, P4, P5 and P6 and the parents of P3, P4 and P6 was subjected to whole exome sequencing. Exome capture was performed with SureSelect Human All Exon kits (Agilent Technologies). Paired-end sequencing was carried out on a HiSeq 2500 sequencing system (Illumina) generating 100-base reads. Sequences were aligned to the GRCh37 reference build of the human genome, using the BWA aligner 43 . Downstream processing and variant calling were performed with the GenomeAnalysis Toolkit 44 , SAMtools 45 and Picard. Substitution and InDel calls were made with the GATK Unified Genotyper. All variants were annotated with an annotation software system that was developed in-house 14 . Putative disease alleles were validated genetically by Sanger sequencing of patient and family genomic DNA.
RNA sequencing. Cell suspensions from freshly isolated bone marrow were obtained from straight chimeras, five WT and five P198A/P198A mutants, 8 weeks after reconstitution, and sorted using a FacsARIA III (BD), using the following gating strategy: viable, B220
. 100 cells per sample were directly sorted into ice cold cell lysis buffer (0.4% (vol/vol) Triton X-100 and 2 U cells were transferred to each well of a six-well plate in a final volume of 4 ml per well. Half the enriched RPMI volume was replaced every 3 days. To initiate further differentiation, actively proliferating cells were then transferred to R20 without IL-7 but containing BAFF (Peprotech) 50− 100 ng ml −1 for 3-4 days, in the presence or absence of BpV(phen). biosensors eCALWY-4 and/or eCALWY-6 engineered with Cerulean (donor) and Citrine (acceptor) 51 targeted either to the cytosol or the endoplasmic reticulum. ER-eCALWY-4 and ER-eCALWY-6 are targeted to the endoplasmic reticulum by an N-terminal preproinsulin sequence and C-terminal Lys-Asp-Glu-Leu (KDEL) sequence. For the purposes of these experiments, the eCALWY constructs were cloned into retroviral pMX-DEST-puro-derived vectors. Filtered retroviral supernatants, harvested 48 h following co-transfection of BOSC23 cells with 7 μ g pCL-Eco and 7 μ g pMX-DEST-puro-derived plasmids, were used to infect the cell cultures in the presence of polybrene (2.5 μ g ml −1 ) and HEPES (20 mM) by spinoculation (850g for 90 min at 30 °C). After a rest period of 4-6 h, viral supernatants were removed and replaced with IL-7-supplemented culture medium. Cultures were maintained in IL-7 media for up to 8-10 days.
Multicolor images were acquired 2-4 days post-transfection using a Leica SP8-X-SMD confocal microscope (Leica Microsystems) with a × 63/1.3 numerical aperture water immersion objective. IL-7-dependent bone marrow B cells were allowed to adhere to poly-L Lysine coated eight-well ibidi chamber slides in phenol red-free RPMI immediately before imaging. Cerulean and Citrine were excited at 440 and 514 nm, respectively, and the fluorescence emission was detected using two hybrid detectors in photon counting mode at 460− 500 and 520-560 nm, respectively. A third channel for propidium iodide was also set to evaluate cell death so that only live cells would be chosen for analysis. Propidium iodide was detected using a HeNe 560 nm laser and a 570-630 nm emission employing a third HyD detector and the same water immersion × 63 objective. Only cells positive for Zn biosensor expression and negative for propidium iodide (typically > 80%) were pre-selected for FLIM acquisition. FRET detection for eCALWY-4 and -6 was based on the time domain FLIM experiments that were performed using a timecorrelated single photon counting approach operated by the FALCON module (Leica Microsystems) integrated on the Leica SP8-X-SMD confocal microscope (Leica Microsystems). A 440 nm picosecond pulsed diode laser PDL 800-B (PicoQuant) tuned at 40 MHz was used to excite the donor (Cerulean) and the emitted photons passing through the 460-500 nm emission filter and were detected using the internal hybrid detector in photon counting mode. At least 1,000 photon events per pixel were collected in all cases (where each pixel equals 152 × 152 nm 2 ) and the lifetime analysis was carried out using the Leica FALCON FLIM integrated software. The acquired fluorescent decays were fitted pixel by pixel binning the images to four and using a background subtraction of around 10-20 photons. A bi-exponential model 52 fixing the Cerulean lifetime to 3.05 ns (ref.
53
) was employed to recover the fraction of interacting donor f D (ref. 52 ), which was then used to recover the relative concentration of Zn
Assay of ZIP7 activity in Xenopus oocytes. Xenopus oocyte expression. Xenopus laevis frogs were purchased from the African Xenopus Facility (South Africa). Care and all experimental procedures were carried out in accordance with UK Home Office guidelines. Oocytes were prepared and maintained as described elsewhere 54 . SLC39A7 plasmids (see above) were further engineered by addition of a RFP tag at the C terminus of either WT or mutant ZIP7. SLC39A7 RNA was transcribed in vitro using the MegaScript T7 kit (Thermo) and 1 µ g of Xba I linearized plasmid DNA as a template. 10 ng per oocyte of RNA were injected and oocytes were incubated 3− 5 days at 18 °C in Barth's solution.
Zn transport assay. Oocytes were incubated in 20 µ M Zinquin (Enzo Life Sciences) for 30 min followed by five washes with Barth's solution. Zinquinloaded oocytes were then incubated for 5 min in 100 µ M ZnCl 2 and visualized using an inverted Nikon TiE microscope (excitation wavelength 380 nm, emission wavelength 510 nm). Images were captured at × 40 using an Andor iXON DU885 EM-CCD camera and Nikon Elements software (v.4.5) . Settings were kept constant throughout each experiment. Multiple images were acquired in parallel focal planes starting at the extracellular matrix of the oocyte and scanning through to the pigmented vesicles, which lie just beneath the plasma membrane. After deconvolution of the images the zinquin signal was visible as discontinuous punctate staining in the intervening, superficial cytoplasm. To quantitate this, representative fields of 50 × 50 µ m 2 were specified and three adjacent focal planes (1.2 µ m interval) were analyzed together in ImageJ. To subtract background staining, ImageJ was used to specify the size (0.2-2 µ m), shape (roundness 0.5-1) and intensity of the 'particles' to be analyzed and a composite measure of signal strength was obtained as the product of their area and intensity. At least three oocytes were analyzed per condition in each of four experiments.
For immunoblotting, 1-5 oocytes were homogenized in 10 µ l of homogenization buffer (1% Elugent (Calbiochem) in 100 mM NaCl 20 mM Tris/ HCl, pH 7.6) per oocyte. Samples were centrifuged at 16,000g for 3 min at room temperature, the supernatant was mixed with an equal volume of SDS gel loading buffer, and visualized by immunoblotting as described 55 .
Endoplasmic reticulum-stress assay. cDNA from cells sorted using the aforementioned gating strategy was used in an XBP-1 splicing PCR with reverse transcription (RT-PCR assay) 56 . PCR products were run on a 2.5% agarose gel. Negative and positive controls were untreated MEFs or MEFs treated with 2 μ g ml 
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Sample size
For the initial characterization of mutant mice, 3-6 animals per group were used in a series of 5 experiments. Control mice were littermates housed in the same cages, age and sex matched. Given that mice were genetically identical with a strong phenotype, we were able to reduce the animal numbers for functional assays to 3 to 5 mice per group , in agreement with the 3Rs recommendations.
In chimera experiments we reconstituted 5-6 mice from each donor, using frozen BM cell suspensions in all cases; donors were age and sex matched; in mixed chimeras, CD45.1 control cells were used fresh. Randomization Mice were weighed, genotyped and used for functional or phenotyping assays in this order. Weighing was performed prior to knowing the genotype. Phenotyping was done on animals with known genotype. As far as possible, groups of mice were equivalent for age and sex.
Blinding no blinding
